Skip to main content
. 2012 Oct 29;7(10):e48314. doi: 10.1371/journal.pone.0048314

Table 3. Tumor-specific SVs validated by PCR and Sanger sequencing.

Type Location Size (kb) Read pairs (#) Gene(s)
TRANSLOCATION chr14-X 21 TCR alpha
chrX-14 14 TCR alpha
DELETION Chr3 59 3 Pag1
Chr5 32.1 3 Agpat9
Chr6 261.8 8 TCR beta
Chr6 479.7 5 TCR beta
Chr6 471.4 3 TCR beta
Chr6 145.1 5 Ig kappa
Chr12 365.7 19 Tmem179
Chr12 53.6 29
Chr12 456.8 6 Aspg, Tmem179, Mir3073, Kif26a
Chr12 56.1 5 Inf2, Adssl1, Siva1
Chr12 14.3 2 Akt1
Chr12 1.3 19 IgH
Chr12 54 5 Tdrd9
Chr12 10.9 32
Chr12 104.4 2 Adssl1, Siva1, Akt1, Zbtb42
Chr13 25.6 29 TCR gamma
Chr14 154 10 TCR alpha
Chr14 366 5 TCR alpha
Chr14 481.9 2 TCR alpha
Chr16 23.1 4 Runx1
Chr18 270.7 5 Arhgap26, Nr3c1
Chr19 538.9 12 Pten
ChrX 1.1 17
INVERSION Chr1 106.1 3
Chr1 1.2 11
Chr12 164.2 5 Inf2, Adssl1, Siva1, Akt1, Zbtb42, AW555464
Chr12 3.7 5 Inf2
Chr12 6 3 Adssl1
Chr12 5.1 28 Tmem179
Chr12 121.4 8 Tdrd9, Aspg
Chr12 533 7 Tdrd9, Aspg, Mir203, Mir3073, Kif26a, Tmem179
Chr12 1.2 7 Inf2
Chr14 1 8 TCR alpha
DUPLICATION Chr8 495.9 3 Cdh13
Chr12 28.9 16 Tdrd9
Chr12 4969 32 IgH
Chr12 3094.8 16 >20 genes
Chr12 3094.4 4 >20 genes